Leukosite has not claimed their Profile.
Want to better differentiate Leukosite between your competitors? Show buyers how.
Why does Leukosite win vs. CoImmune?
Leukosite's alternatives and competitors
See how Leukosite compares to similar products. Leukosite's top competitors include CoImmune, Actinobac Biomed, and Altor BioScience.
CoImmune, fka Argos Therapeutics, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatmen…
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. It…
Leukosite vs. Actinobac BiomedView more in-depth data on:
- Competitors
- Products
- Customer References and more
Altor BioScience is a biopharmaceutical company engaged in the discovery, development and commercialization of high-value, targeted immunotherapeutic agents for the tre…
Leukosite vs. Altor BioScienceView more in-depth data on:
- Competitors
- Products
- Customer References and more
Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer …
Leukosite vs. Acetylon PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
Santaris Pharma is a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discove…
Leukosite vs. Santaris PharmaView more in-depth data on:
- Competitors
- Products
- Customer References and more
GlycoMimetics is developing small molecule drugs that mimic the actions of carbohydrates using glycobiology. The company is focusing its initial efforts on therapeutics…
Leukosite vs. GlycoMimeticsView more in-depth data on:
- Competitors
- Products
- Customer References and more
Mimetogen is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinit…
Leukosite vs. Mimetogen PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
- MI
Micromet is focused on biological products for the treatment and control of cancer, inflammatory and autoimmune diseases. Using its antibody technology platforms, Micro…
Leukosite vs. MicrometView more in-depth data on:
- Competitors
- Products
- Customer References and more
EndGenitor scientists are also engaged in exciting research to novel methods for stimulating and promoting blood vessel formation and growth.
Leukosite vs. EndGenitor TechnologiesView more in-depth data on:
- Competitors
- Products
- Customer References and more
TRF Pharma is a hematology and oncology focused company, developing therapies to treat diseases of abberrant cell adhesion to endothelial (blood vessel) walls. Its prog…
Leukosite vs. TRF PharmaView more in-depth data on:
- Competitors
- Products
- Customer References and more
Peptimmune develops drugs for the treatment of various autoimmune diseases.
Leukosite vs. PeptimmuneView more in-depth data on:
- Competitors
- Products
- Customer References and more
- FA
Favrille is a developer of cancer and autoimmune disease immuno-therapeutics.
Leukosite vs. FavrilleView more in-depth data on:
- Competitors
- Products
- Customer References and more
Rigel Pharmaceuticals discovers and develops drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Their rese…
Leukosite vs. Rigel PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
PROTEOLOGICS develops a class of drugs for viral and other ubiquitin-mediated diseases utilizing technology and knowledge of the ubiquitin system.
Leukosite vs. ProteologicsView more in-depth data on:
- Competitors
- Products
- Customer References and more
Developer of bone marrow graft engineering to expand the use of safe and effective cellular grafts tailored to treat and cure diseases of the immune system and blood sy…
Leukosite vs. Chimeric TherapiesView more in-depth data on:
- Competitors
- Products
- Customer References and more
- BI
BioMs develops biologics for autoimmune diseases with a special emphasis on multiple sclerosis.
Leukosite vs. BioMsView more in-depth data on:
- Competitors
- Products
- Customer References and more
Velbionanotech is designing drugs for various diseases such as Heart Disease, kidney stones, AIDS, Cancer, cosmetic generic products using a short fragment of DNA as a …
Leukosite vs. VelbionanotechnologyView more in-depth data on:
- Competitors
- Products
- Customer References and more
AiRNA's focus is to develop RNAi drugs for cancer, inflammation, and infectious diseases.
Leukosite vs. AiRNA PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
Compete with Leukosite?
Brief our analysts.
Get in front of tech buyers.
100% free.
No pay-to-play nonsense.
Compare Leukosite to Competitors
Can-Fite BioPharma is a biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.
AnaMar Medical is a company in the field of cartilage biology and associated joint diseases. The company has an project portfolio with five drugs and one biomarker in development and two biomarkers on the market.
Virdante Pharmaceuticals is developing safer and more effective drugs for autoimmune and inflammatory diseases. The company's products incorporate a proprietary sialic switch technology to improve the anti-inflammatory properties of antibodies.
Y's Therapeutics focuses on developing monoclonal antibody therapies and other molecular-targeted biological drugs for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs. The company also have small molecule compounds in the company's R&D pipeline to diversify the company's portfolio.
MuriGen is building a portfolio of drugs for unmet medical needs across a number of therapeutic areas including cancer, arthritis, thrombocytopenia, inflammation, epilepsy and thalassemia.
PROTEOLOGICS develops a class of drugs for viral and other ubiquitin-mediated diseases utilizing technology and knowledge of the ubiquitin system.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.